...
首页> 外文期刊>British Journal of Dermatology >Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma
【24h】

Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma

机译:基因表达分析在激进的数字乳头状腺癌棚灯呈稀有汗腺癌的建筑

获取原文
获取原文并翻译 | 示例
           

摘要

Summary Background Sweat gland carcinomas are rare cutaneous adnexal malignancies. Aggressive digital papillary adenocarcinoma ( ADPA ) represents a very rare subentity, thought to arise almost exclusively from the sweat glands of the fingers and toes. The aetiology of sweat gland carcinomas and ADPA is largely unknown. ADPA s are most likely driven by somatic mutations. However, somatic mutation patterns are largely unexplored, creating barriers to the development of effective therapeutic approaches to the treatment of ADPA . Objectives To investigate the transcriptome profile of ADPA using a sample of eight formalin‐fixed, paraffin‐embedded tissue samples of ADPA and healthy control tissue. Methods Transcriptome profiling was performed using the Affymetrix PrimeView Human Gene Expression Microarray and findings were validated via reverse transcription of RNA and real‐time quantitative polymerase chain reaction. Results Transcriptome analyses showed increased tumour expression of 2266 genes, with significant involvement of cell cycle, ribosomal and crucial cancer pathways. Our results point to tumour overexpression of FGFR 2 ( P = 0·001). Conclusions The results indicate the involvement of crucial oncogenic driver pathways, highlighting cell cycle and ribosomal pathways in the aetiology of ADPA . Suggested tumour overexpression of FGFR 2 raises the hope that targeting the fibroblast growth factor ( FGF )/ FGF receptor axis might be a promising treatment for ADPA and probably for the overall group of sweat gland carcinomas.
机译:发明内容背景汗腺腺癌是稀有皮肤缺陷的恶性肿瘤。积极的数字乳头状腺癌(ADPA)代表非常罕见的下列性,以为几乎完全来自手指和脚趾的汗腺。汗腺腺癌和ADPA的病症在很大程度上是未知的。 ADPA S最有可能由躯体突变驱动。然而,体细胞突变模式在很大程度上是未开发的,为治疗ADPA治疗有效治疗方法的发展产生障碍。目的是使用ADPA和健康对照组织的八个福尔马林固定的石蜡包埋的组织样品样品来研究ADPA的转录组谱。方法使用Affymetrix Primeview人类基因表达微阵列进行转录组分析,通过RNA的逆转录和实时定量聚合酶链反应进行验证。结果转录组分析显示出增加2266个基因的肿瘤表达,具有细胞周期,核糖体和关键癌症途径的显着累积。我们的结果指出FGFR 2的肿瘤过度表达(P = 0·001)。结论结果表明关键的致癌驾驶员途径,突出细胞周期和核糖体途径在ADPA的疾病中的累积。建议的FGFR 2的肿瘤过度表达提高了靶向成纤维细胞生长因子(FGF)/ FGF受体轴的希望可能是ADPA的有希望的处理,并且可能是汗液腺癌的整体组。

著录项

  • 来源
    《British Journal of Dermatology》 |2019年第5期|共11页
  • 作者单位

    Heinrich‐Heine‐UniversityDüsseldorf Germany;

    Heinrich‐Heine‐UniversityDüsseldorf Germany;

    Institute for Stem Cell Research and Regenerative MedicineDüsseldorf Germany;

    Pathology Institute for PathologyUniversity Hospital CologneCologne Germany;

    Heinrich‐Heine‐UniversityDüsseldorf Germany;

    Klinikum DarmstadtDepartment of DermatologyDarmstadt Germany;

    Department of DermatologyCarl Gustav Carus Medical CenterDresden Germany;

    Biological and Medical Research Center (BMFZ)Heinrich Heine University DüsseldorfDüsseldorf Germany;

    Biological and Medical Research Center (BMFZ)Heinrich Heine University DüsseldorfDüsseldorf Germany;

    Department of DermatologyCarl Gustav Carus Medical CenterDresden Germany;

    Heinrich‐Heine‐UniversityDüsseldorf Germany;

    Institute for Stem Cell Research and Regenerative MedicineDüsseldorf Germany;

    Institute for Stem Cell Research and Regenerative MedicineDüsseldorf Germany;

    Dermatopathology BodenseeSiemensstrasse 6/1 88048 Friedrichshafen Germany;

    Heinrich‐Heine‐UniversityDüsseldorf Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 皮肤病学与性病学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号